Picture of DOTA-TOC (50 mg)

DOTA-TOC (50 mg)

Precursor for radiolabelled DOTA-TOC

Product No.: DOTA-TOC-95-0050

DOTA-TOC-95

Product No.：DOTA-TOC-95
CAS No.：204318-14-9


Product Name:	DOTA-TOC
Synonyms:	2,2',2''-(10-(2-(((R)-1-(((4R,7S,10S,13R,16S,19R)-13-((1H-indol-3-yl)methyl)-10-(4-aminobutyl)-4- (((2R,3R)-1,3-dihydroxybutan-2-yl)carbamoyl)-16-(4-hydroxybenzyl)-7-((S)-1-hydroxyethyl)-6,9,1 2,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-19-yl)amino)-1-oxo-3-phenylprop an-2-yl)amino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid
CAS No.:	204318-14-9
Molecular Formula:	C₆₅H₉₂N₁₄O₁₈S₂
Molecular Weight:	1421.64
Application:	Percursor for radiolabelled DOTA-TOC
Presentation:	Packaged in amber vial or amber screw cap vials with teflon-coated stoppers under argon atmosphere.

Note

- Care must be taken when handling this product.
- Do not contact skin or eyes.
- Do not ingest or inhale.
- Store at <-20℃. Protect from light.(Short-term storage (<1 month) at higher temperatures (e.g. during transport) does not affect product quality)
- It shall be only used by qualified personnel and only for research.

Order Number

- DOTA-TOC-95-0010x 10mg per vial
  DOTA-TOC-95-0020x 20mg per vial
  note: x includes A B C and D, A refers to 2ml vial; B refers to 4.5ml vial; C refers to 8ml vial; D refers to 30ml vial
  *Customized dispensing is available